DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | A208672 | MACLEODS PHARMACEUTICALS LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Forest Laboratories, LLC et al v. Macleods Pharmaceuticals, Ltd. et al 5 patentsANDA 208672memantine hydrochloride and donepezil hydrochloride | D. Del. | 2017-06-02 | Terminated 2018-03-23 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$11.46
per ea
Lowest NADAC/Unit
$9.70
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 33342031307MEMANTINE-DONEPEZIL ER 28-10 MG | $11.46 | EA | Generic | — | 2026-06-17 |
| 33342031207MEMANTINE-DONEPEZIL ER 14-10 MG | $9.70 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.